Design and Synthesis of Functionally Active 5-Amino-6-Aryl Pyrrolopyrimidine Inhibitors of Hematopoietic Progenitor Kinase 1

Rebecca A. Gallego(Pfizer (United States)), Sajiv K. Nair(Pfizer (United States)), Tongnan Liu(WuXi AppTec (China)), Louise Bernier(Pfizer (United States)), Phương Thu Trần(University of Copenhagen), Michele McTigue(Pfizer (United States)), Robert S. Kania(RG Biopharma (United States)), Michael R. Collins(Pfizer (United States)), Manfred Kraus(Harvard University), Ted W. Johnson(WorldFish), Matthew Del Bel(Pfizer (United States)), Shuiwang Wang(WuXi AppTec (China)), Li Shao, Qiming Mu(Chinese Academy of Agricultural Sciences), Martin P. Edwards(Pfizer (United States)), Jean Matthews(Pfizer (United States)), Sergei Timofeevski(Pfizer (United States)), Mehran Jalaie(Pfizer (United States)), Neal W. Sach(Pfizer (United States)), Nichol Miller(Pfizer (United States)), Ruirui Su(WuXi AppTec (China)), Loanne Chung(Pfizer (United States)), Cinthia Costa Jones(Pfizer (United States)), Allison Rohner(Pfizer (United States)), Xulong Qin(WuXi AppTec (China)), Sujin Cho-Schultz(Pfizer (United States)), Jeff Elleraas(Pfizer (United States)), Ruiduan Huo(WuXi AppTec (China)), Ciarán N. Cronin(Pfizer (United States)), Eric F. Johnson(Pfizer (United States)), Hui Chen(Sun Yat-sen University), Wei Wang(Pfizer (United States)), Bin Sun(WuXi AppTec (China)), Xu Fang(University of Science and Technology of China), Ru Zhou(University of British Columbia), Graham Smith(Queensland University of Technology), Mingying He(Pfizer (United States)), Timothy S. Fisher(Pfizer (United States)), JinJiang Zhu(Pfizer (United States)), Phuong Le, Jacqui Hoffman(Pfizer (United States)), Shijian Ren(WuXi AppTec (China)), Michael Maestre(Pfizer (United States)), Jennifer Lafontaine(Pfizer (United States)), Paul Richardson(Pfizer (United States))
Journal of Medicinal Chemistry
March 20, 2023
Cited by 37


Related Papers